Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

CMR feature tracking in cardiac asymptomatic systemic sclerosis: Clinical implications.

Bratis K, Lindholm A, Hesselstrand R, Arheden H, Karabela G, Stavropoulos E, Katsifis G, Kolovou G, Kitas GD, Sfikakis PP, Koutsogeorgopoulou L, Mavrogeni S, Ostenfeld E.

PLoS One. 2019 Aug 21;14(8):e0221021. doi: 10.1371/journal.pone.0221021. eCollection 2019.

2.

Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases.

Singhania A, Graham CM, Gabryšová L, Moreira-Teixeira L, Stavropoulos E, Pitt JM, Chakravarty P, Warnatsch A, Branchett WJ, Conejero L, Lin JW, Davidson S, Wilson MS, Bancroft G, Langhorne J, Frickel E, Sesay AK, Priestnall SL, Herbert E, Ioannou M, Wang Q, Humphreys IR, Dodd J, Openshaw PJM, Mayer-Barber KD, Jankovic D, Sher A, Lloyd CM, Baldwin N, Chaussabel D, Papayannopoulos V, Wack A, Banchereau JF, Pascual VM, O'Garra A.

Nat Commun. 2019 Jun 28;10(1):2887. doi: 10.1038/s41467-019-10601-6.

3.

Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction.

Mavrogeni SI, Sfikakis PP, Markousis-Mavrogenis G, Bournia VK, Poulos G, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Katsifis G, Boki K, Vartela V, Kolovou G, Theodorakis G, Kitas GD.

Int J Cardiol. 2019 Jun 1;284:105-109. doi: 10.1016/j.ijcard.2018.10.067. Epub 2018 Oct 25.

PMID:
30404725
4.

Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus.

Mavrogeni S, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Bounas A, Tektonidou M, Lliossis SC, Daoussis D, Plastiras S, Karabela G, Stavropoulos E, Katsifis G, Vartela V, Kolovou G.

Lupus. 2018 Apr;27(4):564-571. doi: 10.1177/0961203317731533. Epub 2017 Sep 19.

PMID:
28927316
5.

Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria.

Mavrogeni S, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Katsifis G, Raftakis J, Plastiras S, Noutsias M, Markousis-Mavrogenis G, Kolovou G.

BMC Cardiovasc Disord. 2017 Jul 17;17(1):187. doi: 10.1186/s12872-017-0619-x.

6.

T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection.

Moreira-Teixeira L, Redford PS, Stavropoulos E, Ghilardi N, Maynard CL, Weaver CT, Freitas do Rosário AP, Wu X, Langhorne J, O'Garra A.

J Immunol. 2017 Jul 15;199(2):613-623. doi: 10.4049/jimmunol.1601340. Epub 2017 Jun 5.

7.

Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases.

Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas GD, Sfikakis P, Tektonidou M, Karabela G, Stavropoulos E, Katsifis G, Boki KA, Kitsiou A, Filaditaki V, Gialafos E, Plastiras S, Vartela V, Kolovou G.

Int J Cardiol. 2017 Jun 1;236:151-156. doi: 10.1016/j.ijcard.2017.01.104. Epub 2017 Feb 1.

PMID:
28185705
8.

Microbial Biofilms in Urinary Tract Infections and Prostatitis: Etiology, Pathogenicity, and Combating strategies.

Delcaru C, Alexandru I, Podgoreanu P, Grosu M, Stavropoulos E, Chifiriuc MC, Lazar V.

Pathogens. 2016 Nov 30;5(4). pii: E65. Review.

9.

Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use.

Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH, Kolovou G, Miszalski T, van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas G, Puntmann V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G, Koutsogeorgopoulou L, van Rossum A, Rademakers F, Pohost G, Lima JA.

Int J Cardiol. 2016 Aug 15;217:135-48. doi: 10.1016/j.ijcard.2016.04.158. Epub 2016 Apr 27. Review.

PMID:
27179903
10.

Pseudo-infarction pattern in diffuse systemic sclerosis. Evaluation using cardiovascular magnetic resonance.

Mavrogeni S, Karabela G, Koutsogeorgopoulou L, Stavropoulos E, Katsifis G, Plastiras SC, Kitas GD, Panopoulos S, Pentazos G, Tzatzaki E, Markousis-Mavrogenis G, Kolovou G, Sfikakis PP.

Int J Cardiol. 2016 Jul 1;214:465-8. doi: 10.1016/j.ijcard.2016.03.235. Epub 2016 Apr 8.

PMID:
27096964
11.

Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon Signaling.

Pitt JM, Blankley S, Potempa K, Graham CM, Moreira-Teixeira L, McNab FW, Howes A, Stavropoulos E, Pascual V, Banchereau J, Chaussabel D, O'Garra A.

PLoS One. 2016 Feb 26;11(2):e0150251. doi: 10.1371/journal.pone.0150251. eCollection 2016.

12.

Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance.

Mavrogeni S, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Karabela G, Katsifis G, Stavropoulos E, Gialafos E, Spiliotis G, Kolovou G, Kitas GD.

Inflamm Allergy Drug Targets. 2015;14(2):111-6.

PMID:
26728774
13.

Cardiovascular magnetic resonance evaluation of paediatric patients with systemic lupus erythematosus and cardiac symptoms.

Mavrogeni S, Smerla R, Grigoriadou G, Servos G, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Spiliotis G, Kolovou G, Papadopoulos G.

Lupus. 2016 Mar;25(3):289-95. doi: 10.1177/0961203315611496. Epub 2015 Oct 8.

PMID:
26453663
14.

Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis.

Mavrogeni SI, Bratis K, Karabela G, Spiliotis G, Wijk Kv, Hautemann D, Reiber JH, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Kolovou G, Stavropoulos E.

Inflamm Allergy Drug Targets. 2015;14(1):29-36.

PMID:
26374223
15.

Clinical queries addressed in patients with systemic autoimmune diseases. Can cardiovascular magnetic resonance give the final solution?

Mavrogeni S, Karabela G, Gialafos E, Spiliotis G, Pentazos G, Mylona M, Panopoulos S, Plastiras S, Kolovou G, Stavropoulos E, Boutsikou M, Kitas G, Sfikakis PP.

Inflamm Allergy Drug Targets. 2014;13(5):335-8.

PMID:
25412817
16.

Heart failure imaging patterns in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance.

Mavrogeni S, Karabela G, Stavropoulos E, Plastiras S, Spiliotis G, Gialafos E, Kolovou G, Sfikakis PP, Kitas GD.

Int J Cardiol. 2014 Sep 20;176(2):559-61. doi: 10.1016/j.ijcard.2014.07.016. Epub 2014 Jul 12. No abstract available.

PMID:
25049017
17.

"All roads lead to Rome" ventricular tachycardia due to right ventricle involvement in autoimmune and non-autoimmune disease.

Mavrogeni S, Sfikakis PP, Karabela G, Stavropoulos E, Kolovou G, Kitas GD.

Int J Cardiol. 2014 Apr 15;173(1):126-7. doi: 10.1016/j.ijcard.2014.02.019. Epub 2014 Feb 22. No abstract available.

PMID:
24598233
18.

Cardiovascular magnetic resonance imaging in asymptomatic patients with connective tissue disease and recent onset left bundle branch block.

Mavrogeni S, Sfikakis PP, Karabela G, Stavropoulos E, Spiliotis G, Gialafos E, Panopoulos S, Bournia V, Manolopoulou D, Kolovou G, Kitas G.

Int J Cardiol. 2014 Jan 15;171(1):82-7. doi: 10.1016/j.ijcard.2013.11.059. Epub 2013 Dec 4.

PMID:
24331867
19.

Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases.

Mavrogeni S, Sfikakis PP, Gialafos E, Bratis K, Karabela G, Stavropoulos E, Spiliotis G, Sfendouraki E, Panopoulos S, Bournia V, Kolovou G, Kitas GD.

Arthritis Care Res (Hoboken). 2014 Jan;66(1):104-12. doi: 10.1002/acr.22181.

20.

Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway.

Redford PS, Mayer-Barber KD, McNab FW, Stavropoulos E, Wack A, Sher A, O'Garra A.

J Infect Dis. 2014 Jan 15;209(2):270-4. doi: 10.1093/infdis/jit424. Epub 2013 Aug 9.

21.

Cardiac involvement in ANCA (+) and ANCA (-) Churg-Strauss syndrome evaluated by cardiovascular magnetic resonance.

Mavrogeni S, Karabela G, Gialafos E, Stavropoulos E, Spiliotis G, Katsifis G, Kolovou G.

Inflamm Allergy Drug Targets. 2013 Oct;12(5):322-7.

PMID:
23909889
22.

TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production.

McNab FW, Ewbank J, Rajsbaum R, Stavropoulos E, Martirosyan A, Redford PS, Wu X, Graham CM, Saraiva M, Tsichlis P, Chaussabel D, Ley SC, O'Garra A.

J Immunol. 2013 Aug 15;191(4):1732-43. doi: 10.4049/jimmunol.1300146. Epub 2013 Jul 10.

23.

Imaging patterns of heart failure in rheumatoid arthritis evaluated by cardiovascular magnetic resonance.

Mavrogeni S, Karabela G, Stavropoulos E, Gialafos E, Sfendouraki E, Kyrou L, Kolovou G.

Int J Cardiol. 2013 Oct 9;168(4):4333-5. doi: 10.1016/j.ijcard.2013.05.085. Epub 2013 May 31. No abstract available.

PMID:
23727104
24.

"The silence of lambs": Cardiac lesions in asymptomatic immune-mediated diseases detected by cardiovascular magnetic resonance.

Mavrogeni S, Gialafos E, Karabela G, Stavropoulos E, Sfendouraki E, Kolovou G.

Int J Cardiol. 2013 Oct 3;168(3):2901-2. doi: 10.1016/j.ijcard.2013.03.164. Epub 2013 May 9. No abstract available.

PMID:
23664046
25.

Diffuse, subendocardial vasculitis. A new entity identified by cardiovascular magnetic resonance and its clinical implications.

Mavrogeni S, Sfikakis PP, Gialafos E, Karabela G, Stavropoulos E, Sfendouraki E, Panopoulos S, Kolovou G, Kitas GD.

Int J Cardiol. 2013 Oct 3;168(3):2971-2. doi: 10.1016/j.ijcard.2013.04.116. Epub 2013 May 4. No abstract available.

PMID:
23647593
26.

Myocarditis during acute inflammatory myopathies: evaluation using clinical criteria and cardiac magnetic resonance imaging.

Mavrogeni S, Bratis K, Karabela G, Stavropoulos E, Sfendouraki E, Kolovou G.

Int J Cardiol. 2013 Mar 20;164(1):e3-4. doi: 10.1016/j.ijcard.2012.09.109. Epub 2012 Sep 27. No abstract available.

PMID:
23022085
27.

Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.

Pitt JM, Stavropoulos E, Redford PS, Beebe AM, Bancroft GJ, Young DB, O'Garra A.

J Immunol. 2012 Oct 15;189(8):4079-87. doi: 10.4049/jimmunol.1201061. Epub 2012 Sep 12.

28.

Myocardial perfusion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonance.

Mavrogeni S, Bratis K, van Wijk K, Stavropoulos E, Hautemann D, Reiber JH, Kolovou G.

Int J Cardiol. 2012 Sep 6;159(3):e56-8. doi: 10.1016/j.ijcard.2011.12.039. Epub 2012 Jan 9. No abstract available.

PMID:
22227256
29.

Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung.

Redford PS, Boonstra A, Read S, Pitt J, Graham C, Stavropoulos E, Bancroft GJ, O'Garra A.

Eur J Immunol. 2010 Aug;40(8):2200-10. doi: 10.1002/eji.201040433.

30.

Influence of the developmental stage on the (proto)-hypericin and (proto)pseudohypericin levels of Hypericum plants from Crete.

Xenophontos M, Stavropoulos E, Avramakis E, Navakoudis E, Dörnemann D, Kotzabasis K.

Planta Med. 2007 Oct;73(12):1309-15. Epub 2007 Sep 24.

PMID:
17893828
31.

Induction of high levels of protective immunity in mice after vaccination using dendritic cells infected with auxotrophic mutants of Mycobacterium tuberculosis.

Roy E, De Silva AD, Sambandamurthy VK, Clark SO, Stavropoulos E, Jacobs WR Jr, Brennan J, Chan J, Williams A, Colston MJ, Tascon RE.

Immunol Lett. 2006 Mar 15;103(2):196-9. Epub 2005 Nov 2.

PMID:
16297449
32.

Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice.

Roy E, Stavropoulos E, Brennan J, Coade S, Grigorieva E, Walker B, Dagg B, Tascon RE, Lowrie DB, Colston MJ, Jolles S.

Infect Immun. 2005 Sep;73(9):6101-9.

33.

Static balance improvement in elderly after dorsiflexors electrostimulation training.

Amiridis I, Arabatzi F, Violaris P, Stavropoulos E, Hatzitaki V.

Eur J Appl Physiol. 2005 Jul;94(4):424-33. Epub 2005 Apr 21.

PMID:
15843959
34.
35.

RNA encoding the MPT83 antigen induces protective immune responses against Mycobacterium tuberculosis infection.

Xue T, Stavropoulos E, Yang M, Ragno S, Vordermeier M, Chambers M, Hewinson G, Lowrie DB, Colston MJ, Tascon RE.

Infect Immun. 2004 Nov;72(11):6324-9.

36.

Antimycobacterial calixarenes enhance innate defense mechanisms in murine macrophages and induce control of Mycobacterium tuberculosis infection in mice.

Colston MJ, Hailes HC, Stavropoulos E, Hervé AC, Hervé G, Goodworth KJ, Hill AM, Jenner P, Hart PD, Tascon RE.

Infect Immun. 2004 Nov;72(11):6318-23.

37.

A recA deletion mutant of Mycobacterium bovis BCG confers protection equivalent to that of wild-type BCG but shows increased genetic stability.

Sander P, Böttger EC, Springer B, Steinmann B, Rezwan M, Stavropoulos E, Joseph Colston M.

Vaccine. 2003 Oct 1;21(27-30):4124-7.

PMID:
14505891
38.

Evaluation of the association of autoantibodies with mortality in the very elderly: a cohort study.

Ioannidis JP, Katsifis GE, Stavropoulos ED, Manoussakis MN, Moutsopoulos HM.

Rheumatology (Oxford). 2003 Feb;42(2):357-61.

PMID:
12595636
39.

Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model.

Sander P, Papavinasasundaram KG, Dick T, Stavropoulos E, Ellrott K, Springer B, Colston MJ, Böttger EC.

Infect Immun. 2001 Jun;69(6):3562-8.

40.

Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice.

Tascon RE, Soares CS, Ragno S, Stavropoulos E, Hirst EM, Colston MJ.

Immunology. 2000 Mar;99(3):473-80.

41.

Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain.

Brosch R, Philipp WJ, Stavropoulos E, Colston MJ, Cole ST, Gordon SV.

Infect Immun. 1999 Nov;67(11):5768-74. Erratum in: Infect Immun 2000 Jan;68(1):427.

42.

Therapy of tuberculosis in mice by DNA vaccination.

Lowrie DB, Tascon RE, Bonato VL, Lima VM, Faccioli LH, Stavropoulos E, Colston MJ, Hewinson RG, Moelling K, Silva CL.

Nature. 1999 Jul 15;400(6741):269-71.

PMID:
10421369
43.

Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon.

Tascon RE, Stavropoulos E, Lukacs KV, Colston MJ.

Infect Immun. 1998 Feb;66(2):830-4.

44.

Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis.

Heym B, Stavropoulos E, Honoré N, Domenech P, Saint-Joanis B, Wilson TM, Collins DM, Colston MJ, Cole ST.

Infect Immun. 1997 Apr;65(4):1395-401.

45.

Vaccination against tuberculosis by DNA injection.

Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB.

Nat Med. 1996 Aug;2(8):888-92.

PMID:
8705858
46.

Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients.

Roitberg-Tambur A, Friedmann A, Safirman C, Markitziu A, Ben-Chetrit E, Rubinow A, Moutsopoulos HM, Stavropoulos E, Skopouli FN, Margalit H, et al.

Hum Immunol. 1993 Apr;36(4):235-42.

PMID:
8340232
47.

The effects of peripheral cold exposure on oesophageal motility in patients with autoimmune rheumatic diseases and Raynaud's phenomenon.

Tsianos EV, Berecos C, Stavropoulos E, Kazazis E, Danielides IC, Drosos AA.

Clin Rheumatol. 1991 Sep;10(3):311-5.

PMID:
1790643
48.

Determination of anti-ds-DNA antibodies by three different methods: comparison of sensitivity, specificity and correlation with lupus activity index (LAI).

Tzioufas AG, Terzoglou C, Stavropoulos ED, Athanasiadou S, Moutsopoulos HM.

Clin Rheumatol. 1990 Jun;9(2):186-92.

PMID:
2202542
49.

Soluble interleukin-2 receptors and autoantibodies in the serum of healthy elderly individuals.

Manoussakis MN, Stavropoulos ED, Germanidis GS, Papasteriades CA, Garalea KL, Dontas AS, Moutsopoulos HM.

Autoimmunity. 1990;7(2-3):129-37.

PMID:
2104181
50.

Sjögren's syndrome in progressive systemic sclerosis.

Drosos AA, Andonopoulos AP, Costopoulos JS, Stavropoulos ED, Papadimitriou CS, Moutsopoulos HM.

J Rheumatol. 1988 Jun;15(6):965-8.

PMID:
3418646

Supplemental Content

Loading ...
Support Center